Left Atrial Appendage Occlusion in Octogenarians: Short-Term and 1-Year Follow-Up

被引：38

作者：

Gafoor, Sameer ^{[1
]}

Franke, Jennifer ^{[2
]}

Bertog, Stefan ^{[1
,3
]}

Boehm, Patrick ^{[1
]}

Heuer, Luisa ^{[1
]}

Gonzaga, Maik ^{[1
]}

Bauer, Janine ^{[1
]}

Braut, Annkathrin ^{[1
]}

Lam, Simon ^{[1
]}

Vaskelyte, Laura ^{[1
]}

Hofmann, Ilona ^{[1
]}

Sievert, Horst ^{[1
]}

机构：

[1] Ctr Cardiovasc, Frankfurt, Germany

[2] Heidelberg Univ, Heidelberg, Germany

[3] Vet Affairs Med Ctr, Minneapolis, MN USA

来源：

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS | 2014年 / 83卷 / 05期

关键词：

LAC - Left Atrial Appendage Closure; COMP - Complications adult cath; intervention; PERI; -; Pericardial; ORAL ANTICOAGULANTS; WARFARIN THERAPY; FIBRILLATION; STROKE; PREVENTION; ASPIRIN; CLOPIDOGREL; CLOSURE; SINGLE;

D O I：

10.1002/ccd.25297

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

ObjectivesTo determine the procedural safety, safety, and efficacy of left atrial appendage (LAA) occlusion in octogenarians. BackgroundElderly patients with atrial fibrillation (AF) often do not receive appropriate anticoagulation. LAA occlusion is an option for patients with AF and contraindications to anticoagulation. Not much is known about the procedural safety and clinical efficacy of LAA occlusion in the very elderly. MethodsA retrospective review of LAA cases at our institution between 2002 and 2013 in patients 80 years of age or older was performed. Demographic, echocardiographic, procedural, and clinical follow-up data were collected. ResultsSeventy-five cases were attempted in patients 80 years of age or older (average age 83.42.8 years, 53.3% males). Hypertension, coronary artery disease, and heart failure were present in 96, 41.3, and 36%, respectively. Mean CHADS2 and CHA2DS-VASc scores were 3.3 and 5.2. Devices used included the WATCHMAN, ACP, PLAATO, Lariat, and Coherex devices, which were attempted in 34.7, 36, 17.3, 5.3, and 5.3%, respectively. Overall procedural success, safety endpoint, and 1-year device efficacy was 90.1, 3.9, and 97.4%, respectively. ConclusionLAA closure is a safe and efficacious method of stroke prevention in the very elderly with AF. (c) 2013 Wiley Periodicals, Inc.

引用

页码：805 / 810

页数：6

共 20 条

[1]

Bayard YL, 2010, EUROINTERVENTION, V6, P220, DOI 10.4244/

[2]

Berthold HK, 2012, Z GERONTOL GERIATR, V45, P498, DOI 10.1007/s00391-012-0377-4

[3] Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation [J].

Blackshear, JL ;

Odell, JA .

ANNALS OF THORACIC SURGERY, 1996, 61 (02) :755-759

[4] Percutaneous Left Atrial Appendage Occlusion for Patients in Atrial Fibrillation Suboptimal for Warfarin Therapy 5-Year Results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study [J].

Block, Peter C. ;

Burstein, Steven ;

Casale, Paul N. ;

Kramer, Paul H. ;

Teirstein, Paul ;

Williams, David O. ;

Reisman, Mark .

JACC-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (07) :594-600

[5] Why do patients with atrial fibrillation not receive warfarin? [J].

Bungard, TJ ;

Ghali, WA ;

Teo, KK ;

McAlister, FA ;

Tsuyuki, RT .

ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (01) :41-46

[6] Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation [J].

Connolly, S. J. ;

Yusuf, S. ;

Camm, J. ;

Chrolavicius, S. ;

Commerford, P. ;

Flather, M. ;

Hart, R. G. ;

Hohnloser, S. H. ;

Joyner, C. ;

Pfeffer, M. ;

Gaudin, C. ;

Blumenthal, M. ;

Marchese, C. ;

Pogue, J. ;

Hart, R. ;

Hohnloser, S. ;

Anand, I. ;

Arthur, H. ;

Avezum, A. ;

Budaj, A. ;

Ceremuzynski, L. ;

De Caterina, R. ;

Diaz, R. ;

Dorian, P. ;

Flaker, G. ;

Fox, K. A. A. ;

Franzosi, M. G. ;

Goldhaber, S. ;

Golitsyn, S. ;

Granger, C. ;

Halon, D. ;

Hermosillo, A. ;

Hunt, D. ;

Jansky, P. ;

Karatzas, N. ;

Keltai, M. ;

Kozan, O. ;

Lanas, F. ;

Lau, P. ;

Le Heuzey, J. Y. ;

Lewis, B. S. ;

Morais, J. ;

Morillo, C. ;

Paolasso, E. ;

Peters, R. J. ;

Pfisterer, M. ;

Piegas, L. ;

Pipilis, A. ;

Sitkei, E. ;

Swedberg, K. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (20) :2066-2078

[7] Dabigatran versus Warfarin in Patients with Atrial Fibrillation. [J].

Connolly, Stuart J. ;

Ezekowitz, Michael D. ;

Yusuf, Salim ;

Eikelboom, John ;

Oldgren, Jonas ;

Parekh, Amit ;

Pogue, Janice ;

Reilly, Paul A. ;

Themeles, Ellison ;

Varrone, Jeanne ;

Wang, Susan ;

Alings, Marco ;

Xavier, Denis ;

Zhu, Jun ;

Diaz, Rafael ;

Lewis, Basil S. ;

Darius, Harald ;

Diener, Hans-Christoph ;

Joyner, Campbell D. ;

Wallentin, Lars .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) :1139-1151

[8] Validation of clinical classification schemes for predicting stroke - Results from the national registry of Atrial Fibrillation [J].

Gage, BF ;

Waterman, AD ;

Shannon, W ;

Boechler, M ;

Rich, MW ;

Radford, MJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (22) :2864-2870

[9] A Review of Oral Anticoagulants in Patients with Atrial Fibrillation [J].

Greenspon, Arnold J. .

POSTGRADUATE MEDICINE, 2012, 124 (06) :7-16

[10] LESS IS MORE Risk of Bleeding With Single, Dual, or Triple Therapy With Warfarin, Aspirin, and Clopidogrel in Patients With Atrial Fibrillation [J].

Hansen, Morten L. ;

Sorensen, Rikke ;

Clausen, Mette T. ;

Fog-Petersen, Marie Louise ;

Raunso, Jakob ;

Gadsboll, Niels ;

Gislason, Gunnar H. ;

Folke, Fredrik ;

Andersen, Soren S. ;

Schramm, Tina K. ;

Abildstrom, Steen Z. ;

Poulsen, Henrik E. ;

Kober, Lars ;

Torp-Pedersen, Christian .

ARCHIVES OF INTERNAL MEDICINE, 2010, 170 (16) :1433-1441

← 1 2 →